Cancer risk of Janus kinase inhibitors and other advanced therapies in immune-mediated inflammatory diseases: a systematic review and Bayesian network meta-analysis of RCTs.
- DOI
- 10.1016/j.ard.2026.06.017
- Published
- 2026-07-10
- Container
- Ann Rheum Dis
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ard.2026.06.017,
title = {Cancer risk of Janus kinase inhibitors and other advanced therapies in immune-mediated inflammatory diseases: a systematic review and Bayesian network meta-analysis of RCTs.},
author = {Gibson M and Allen V and Adas M and Muzafar I and Muzafar S and Suresh N and Yoon Y and De Gracia L and Chavali R and Hussain H and Mootoo A and Brown J and Bechman K and Russell M and Norton S and Phillippo D and Welton N and Galloway J.},
year = {2026},
journal = {Ann Rheum Dis},
doi = {10.1016/j.ard.2026.06.017},
url = {https://doi.org/10.1016/j.ard.2026.06.017}
}RIS
TY - JOUR TI - Cancer risk of Janus kinase inhibitors and other advanced therapies in immune-mediated inflammatory diseases: a systematic review and Bayesian network meta-analysis of RCTs. AU - Gibson M AU - Allen V AU - Adas M AU - Muzafar I AU - Muzafar S AU - Suresh N AU - Yoon Y AU - De Gracia L AU - Chavali R AU - Hussain H AU - Mootoo A AU - Brown J AU - Bechman K AU - Russell M AU - Norton S AU - Phillippo D AU - Welton N AU - Galloway J. PY - 2026 JO - Ann Rheum Dis DO - 10.1016/j.ard.2026.06.017 UR - https://doi.org/10.1016/j.ard.2026.06.017 ER -
APA
M, G., V, A., M, A., I, M., S, M., N, S., Y, Y., L, D. G., R, C., H, H., A, M., J, B., K, B., M, R., S, N., D, P., N, W., & J., G. (2026). Cancer risk of Janus kinase inhibitors and other advanced therapies in immune-mediated inflammatory diseases: a systematic review and Bayesian network meta-analysis of RCTs.. Ann Rheum Dis. https://doi.org/10.1016/j.ard.2026.06.017
Source records
- europe-pmc · retrieved 2026-09-25T04:55:10.623Z